News
1h
News-Medical.Net on MSNHow the Vutara VXL simplifies single-molecule imaging
The Vutara VXL is a benchtop optical microscope that's been optimized specifically for single-molecule localization. It uses ...
In a discovery that can one day revolutionize cancer treatment, researchers at the University of California, Riverside have successfully developed a means of controlling MYC, a notoriously slippery ...
Predictive health powered by multi-omic testing is shifting care from reactive to preventive, enabling early disease detection, lower costs, and longer healthspans.
16h
Interesting Engineering on MSNMIT’s next-gen AI screens millions of molecules at supercomputer speed for drug study
Boltz 2 helps pharma triage vast molecular libraries, turning compute heavy screening into near real time decisions.
15h
News-Medical.Net on MSNScientists link gut microbes to stronger muscles and healthier aging
Researchers discovered that gut microbes, including Lactobacillus reuteri and L. johnsonii, can enhance muscle strength in ...
Robert Francis Kennedy Jr. has always been a man in the middle of storms, sometimes as a celebrated environmental champion, ...
1h
Health and Me on MSNScientists Recreate Rare Mutation That Could Make You Nearly Immune To All Viruses
Could a single rare genetic tweak shield humans from nearly every virus for days? Scientists may have just cracked the code.
Epigenetic regulation plays a critical role in the reshaping of gene expression programs, ultimately driving cancer ...
Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American ...
Dubbed the ‘guardian of the genome’, the p53 protein responds to DNA damage by stalling cell division, initiating DNA repair or triggering cell death. This well-known pathway is frequently mutated or ...
Phosphoramidite market was valued at US$ 1.21 billion in 2024 and is projected to hit the market valuation of US$ 2.44 billion by 2033 at a CAGR of 8.1% during the forecast period 2025–2033. A Request ...
U.S. FDA has placed a clinical hold on the Phase 2b study as it reviews data submitted by BiomX on third-party nebulizer used to deliver BX004; no concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results